Alnylam Pharmaceuticals, Inc. (ALNY): Revenue
$3.71B
Year ended 2025-12-31
$4.80B
Trailing 12 months to 2026-06-30
+53.0%
3-year compound annual growth
+49.8%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.71B | +65.2% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | $2.25B | +23.0% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $1.83B | +76.2% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | $1.04B | +22.9% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $844.29M | +71.3% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $492.85M | +124.3% | 2021-02-11, From 2020-01-01 |
| 2019-12-31 | $219.75M | +193.4% | 2021-02-11, From 2019-01-01 |
| 2018-12-31 | $74.91M | -16.7% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $89.91M | +90.7% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $47.16M | n/a | 2019-02-14, From 2016-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $3.71B | +65.2% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $4.25B | -2.8% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $4.27B | +4.9% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $3.22B | +12.9% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $3.18B | +10.6% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $3.02B | +8.0% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $4.71B | +6.2% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $5.34B | +40.2% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $2.38B | +5.1% |
Compare ALNY, PRGO, JAZZ, BMRN side by side · Screen every company in Pharmaceutical Preparations ↗